These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12058967)

  • 1. Sensitivity of p53-deficient cells to oxaliplatin and thio-TEPA (N, N', N" triethylenethiophosphoramide).
    Seo YR; Chen EI; Smith ML
    Breast Cancer Res Treat; 2002 Apr; 72(3):255-63. PubMed ID: 12058967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2.
    Fedier A; Ruefenacht UB; Schwarz VA; Haller U; Fink D
    Br J Cancer; 2002 Oct; 87(9):1027-33. PubMed ID: 12434296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair.
    Manic S; Gatti L; Carenini N; Fumagalli G; Zunino F; Perego P
    Curr Cancer Drug Targets; 2003 Feb; 3(1):21-9. PubMed ID: 12570658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of N,N',N''-triethylenethiophosphoramide and N,N',N''-triethylenephosphoramide with cellular DNA.
    Cohen NA; Egorin MJ; Snyder SW; Ashar B; Wietharn BE; Pan SS; Ross DD; Hilton J
    Cancer Res; 1991 Aug; 51(16):4360-6. PubMed ID: 1714342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
    Chiu SJ; Lee YJ; Hsu TS; Chen WS
    Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells.
    Wang X; Li M; Wang J; Yeung CM; Zhang H; Kung HF; Jiang B; Lin MC
    Biochem Pharmacol; 2006 May; 71(11):1540-50. PubMed ID: 16595125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells.
    Toscano F; Parmentier B; Fajoui ZE; Estornes Y; Chayvialle JA; Saurin JC; Abello J
    Biochem Pharmacol; 2007 Aug; 74(3):392-406. PubMed ID: 17559811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
    O'Neill CF; Hunakova L; Kelland LR
    Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mammalian cells against chemotherapeutic agents thiotepa, 1,3-N,N'-bis(2-chloroethyl)-N-nitrosourea, and mafosfamide using the DNA base excision repair genes Fpg and alpha-hOgg1: implications for protective gene therapy applications.
    Xu Y; Hansen WK; Rosenquist TA; Williams DA; Limp-Foster M; Kelley MR
    J Pharmacol Exp Ther; 2001 Mar; 296(3):825-31. PubMed ID: 11181913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential roles of p53 tumor suppressor in nucleotide excision repair (NER) and base excision repair (BER).
    Seo YR; Jung HJ
    Exp Mol Med; 2004 Dec; 36(6):505-9. PubMed ID: 15665582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
    Reardon JT; Vaisman A; Chaney SG; Sancar A
    Cancer Res; 1999 Aug; 59(16):3968-71. PubMed ID: 10463593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.
    Gatti L; Supino R; Perego P; Pavesi R; Caserini C; Carenini N; Righetti SC; Zuco V; Zunino F
    Cell Death Differ; 2002 Dec; 9(12):1352-9. PubMed ID: 12478472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
    Lim SC; Choi JE; Kang HS; Han SI
    Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells.
    Faivre S; Chan D; Salinas R; Woynarowska B; Woynarowski JM
    Biochem Pharmacol; 2003 Jul; 66(2):225-37. PubMed ID: 12826265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
    Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-independent response to cisplatin and oxaliplatin in MMTV-ras mouse salivary tumors.
    Petit T; Bearss DJ; Troyer DA; Munoz RM; Windle JJ
    Mol Cancer Ther; 2003 Feb; 2(2):165-71. PubMed ID: 12589033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells.
    Nehmé A; Baskaran R; Nebel S; Fink D; Howell SB; Wang JY; Christen RD
    Br J Cancer; 1999 Mar; 79(7-8):1104-10. PubMed ID: 10098743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular processing of platinum anticancer drugs.
    Wang D; Lippard SJ
    Nat Rev Drug Discov; 2005 Apr; 4(4):307-20. PubMed ID: 15789122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.